ReviewTissue engineering and regenerative medicine2016
Angiogenic potential of extracellular matrix of human amniotic membrane.
Review in Tissue engineering and regenerative medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Human amniotic membrane: an improvement in the treatment of Medication-related osteonecrosis of the jaw (MRONJ)? A case-control study.Cell and tissue banking · 2022Trial
- Evaluation of Two Methods for Decellularizing Human Amniotic Membranes for Use in Tissue Engineering.Methods and protocols · 2026Article
- Well-regulated Dermal Regeneration Using Amnion-containing Scaffold in a Preclinical Study.Advanced pharmaceutical bulletin · 2025Article
- Vessel-Derived Decellularized Extracellular Matrices (VdECM): Novel Bio-Engineered Materials for the Wound Healing.Tissue engineering and regenerative medicine · 2023Article
- Tissue-engineered amniotic membrane in the treatment of myocardial infarction: a systematic review of experimental studies.American journal of cardiovascular disease · 2021Review
- Development of Injectable Amniotic Membrane Matrix for Postmyocardial Infarction Tissue Repair.Advanced healthcare materials · 2020Article
- Comparative preclinical assessment of the use of dehydrated human amnion/chorion membrane to repair perforated sinus membranes.Journal of periodontal & implant science · 2019Article
- Characterization of burn wound healing gel prepared from human amniotic membrane and Aloe vera extract.BMC complementary and alternative medicine · 2019Article
- Retraction: Tumor Targeting by Conditioned Medium Derived from Human Amniotic Membrane: New Insight in Breast Cancer Therapy.Technology in cancer research & treatmentArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Combination between tissue engineering and other fields has brought an innovation in the area of regenerative medicine which ultimate aims are to repair, improve, and produce a good tissue construct. The availability of many types of scaffold, both synthetically and naturally have developed into many outstanding end products that have achieved the general objective in tissue engineering. Interestingly, most of this scaffold emulates extracellular matrix (ECM) characteristics. Therefore, ECM component sparks an interest to be explored and manipulated. The ECM featured in human amniotic membrane (HAM) provides a suitable niche for the cells to adhere, grow, proliferate, migrate and differentiate, and could possibly contribute to the production of angiogenic micro-environment indirectly. Previously, HAM scaffold has been widely used to accelerate wound healing, treat bone related and ocular diseases, and involved in cardiovascular repair. Also, it has been used in the angiogenicity study, but with a different technical approach. In addition, both side of HAM could be used in cellularised and decellularised conditions depending on the objectives of a particular research. Therefore, it is of paramount importance to investigate the behavior of ECM components especially on the stromal side of HAM and further explore the angiogenic potential exhibited by this scaffold.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.